- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
MNMD Stock: The FDA Go-Ahead That Has MindMed Investors Feeling Euphoric Today
MindMed (MNMD) stock is getting a buzz today thanks to approval from the FDA to move forward with a clinical trial of MM-120.
NVAX Stock: 5 Things to Know About Novavax’s Omicron-Fighting News
Despite NVAX stock being lower, Novavax announced promising data based on initial results of a study. Here’s what you should know.
NVAX Stock: Novavax Climbs on New Vaccine Manufacturing Deal
Novavax continues to excite investors with new plans to expand its manufacturing capacity for its coronavirus vaccine. Here’s what to know.
Flu’s Pain Is All Gain for These Companies
As this year’s flu season intensifies, so do the profits for some businesses such as vaccine makers, pharmacies and even certain food and beverage makers.
Inovio Stock Shows Plenty of Promise Ahead
The clinical results from Inovo’s INO-4700 validate the upside potential in INO stock.
Novavax Stock Won’t Have Legs in a Reduced-Covid World
There are signs that the pandemic may end soon, and Novavax has had serious supply issues. As a result, NVAX stock looks too risky.
Is It Time to Go Long on VBIV Stock?
As a speculative pharmaceutical investment, VBIV stock is not for the faint of heart. However, the underlying business suggests some rationale for longer-term optimism.
Novavax Stock Is a Buy After This Overdone Sell-Off
NVAX stock dropped too sharply on a negative Reuters article about Novavax, creating a great buying opportunity for investors.
Covid-19 Vaccine Dose Delay Spells Even More Trouble for Novavax Stock
Investors might hope that the spread of the Delta variant will boost NVAX stock, but a recent news release is likely to hinder progress.
5 Stocks With Ugly Free Cash Flow — GBSN I HTZ RGSE CCCL
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Free Cash Flow — I CCCL RGSE CMLS RLJE
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Free Cash Flow — CETC RGSE I CCCL CMLS
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Weak Free Cash Flow — RGSE I CCCL CMLS RLJE
This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.
Why Wells Fargo & Co (WFC) Stock Can’t Climb Out of This Hole
WFC stock may be up 36% since October, but a double-dose of bad news for Wells Fargo this week suggests it can’t escape its checkered…
Want to Play Renewable Energy? Focus on the New YieldCos
Just like MLPs & REITs, YieldCos can a dose of high dividends to your portfolio. Here’s a look at how they work and why they’re…
Paul Krugman May Be the World’s Last Flat Earth Economist
Dr. Paul Krugman’s ideas on how to turn the economy around could use a little dose of reality, and the correct way to move forward…
Marijuana Stocks: GW Phamaceuticals Stock Surges on Late-Stage Study Success
There was good news for marijuana stocks today after GW Phamaceuticals (GWPH) announced recent results from a late-stage study.
Regeneron Shares Get a Spark
A decision by the VA has lifted prospects for the company’s key drug — and its stock.
Drug Warning: Why Everyone Is Afraid of New Painkiller Zohydro
Zohydro, a new prescription painkiller being made by Zogenix and Alkermes, has almost everyone on edge due to how powerful and addictive it is.
Why This Fundamentally Superior Biotech Is Soaring
This biotech stock has had a good run-up as of late. But does that mean it should be the only one you invest in? Nope.…
As a Vaccine Looks More Likely, Moderna Stock Still Is a Good Bet
Pharmaceutical company Moderna is at the forefront of the global race to develop a vaccine against Covid-19. We could know as early as October whether…
Ocugen Looks Perched and Ready to Blow Through $18
Ocugen had a strong April gaining a whopping 87% for the month. OCGN stock is now up 313% on the year. It seems $18 is…
Carnival’s Outlook Has Improved as We Get Closer to a Vaccine
The outlook on CCL stock has improved significantly. But the airlines stocks are still a much better bet than Carnival.
9 – 10 of 240 results
